XML 68 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Feb. 23, 2014
Feb. 24, 2013
Consolidated net income $ 14,726,000 $ 18,227,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,364,000 5,527,000
Stock-based compensation expense 992,000 1,135,000
Tax benefit from stock-based compensation expense (1,909,000) (2,743,000)
Loss on disposal of property and equipment 330,000 180,000
Deferred taxes 5,286,000 4,230,000
Contingent Consideration   (3,933,000)
Change in investment in non-public company (fair market value) (8,100,000) (6,300,000)
Changes in current assets and current liabilities:    
Accounts receivable, net (4,969,000) (5,316,000)
Accounts receivable, related party 482,000 11,000
Income taxes receivable 2,798,000 2,790,000
Inventories, net (1,555,000) (374,000)
Prepaid expenses and other current assets (203,000) (3,620,000)
Accounts payable (1,845,000) 5,096,000
Accounts payable, related party (677,000) (585,000)
Accrued compensation 147,000 131,000
Other accrued liabilities 2,541,000 (2,564,000)
Deferred revenue 426,000 1,583,000
Net cash provided by operating activities 13,834,000 13,475,000
Purchases of property and equipment (10,192,000) (4,538,000)
Purchase of marketable securities (1,417,000) (5,239,000)
Net cash used in investing activities (8,647,000) (8,328,000)
Proceeds from sale of common stock 2,147,000 1,385,000
Taxes paid by Company for stock swaps and RSUs (1,252,000) (49,000)
Tax benefit from stock-based compensation expense 1,909,000 2,743,000
Earn out payment from Lifecore acquisition   (9,650,000)
Payments on long-term debt (4,525,000) (4,476,000)
Proceeds from lines of credit 3,500,000  
Payments on lines of credit (7,500,000) (7,666,000)
Decrease in other assets 29,000 652,000
Payments to minority interest holders (226,000) (320,000)
Net cash used in financing activities (5,918,000) (17,381,000)
Net decrease in cash and cash equivalents (731,000) (12,234,000)
Cash and cash equivalents at beginning of period 13,718,000 22,177,000
Cash and cash equivalents at end of period 12,987,000 9,943,000
Earnout [Member]
   
Adjustments to reconcile net income to net cash provided by operating activities:    
Contingent Consideration   (3,933,000)
Change In Value [Member]
   
Adjustments to reconcile net income to net cash provided by operating activities:    
Contingent Consideration   3,933,000
Marketable Maturities [Member]
   
Changes in current assets and current liabilities:    
Proceeds from maturities of marketable securities $ 2,962,000 $ 1,449,000